Loading…
for educational and safety purposes
Pramiracetam and Piracetam both come up in the same conversations; they overlap on Acetylcholine. Pramiracetam: Pramiracetam is a laboratory-made compound in the piracetam ("racetam") family, developed by Parke-Davis as CI-879 and later sold in a few European countries as a prescription memory drug under the brand name Pramistar. Piracetam: Piracetam is the original nootropic, the very compound for which the word 'nootropic' was coined, developed by Corneliu Giurgea in the late 1960s to enhance learning and memory [1].
Pramiracetam is a laboratory-made compound in the piracetam ("racetam") family, developed by Parke-Davis as CI-879 and later sold in a few European countries as a prescription memory drug under the brand name Pramistar. It is meant to improve memory and attention; in animals it reliably increases the rate at which brain cells take up choline, a building block of the memory-related signalling chemical acetylcholine, but no receptor that it binds to has ever been identified. Human evidence is thin: a small placebo-controlled trial in men with head injuries reported better delayed recall, and a study in healthy volunteers found it partly blunted drug-induced forgetting, while a trial in Alzheimer's disease found no benefit even at high doses. The entire published literature is roughly 40 papers, most of them small, decades old, or done in rodents, so confident claims that it strongly enhances cognition in healthy people are not supported by what has actually been measured.
Piracetam is the original nootropic, the very compound for which the word 'nootropic' was coined, developed by Corneliu Giurgea in the late 1960s to enhance learning and memory [1]. A cyclic derivative of the neurotransmitter GABA, it has become the foundational template of the entire racetam family and remains one of the most widely studied cognitive enhancers in the world [1][4]. Prized for a remarkable safety record and effects that are most pronounced when brain function is impaired, piracetam supports memory, learning, and cerebral circulation, and is used clinically for cognitive decline, myoclonus, and stroke recovery [2][4][5].
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
enhances
Permissive requirement, not a direct target; memory effect is abolished without intact steroid signalling
raises
Normalises scopolamine-induced changes in choline permeability; increases cerebral blood flow
No measurable affinity
Increases enzyme activity without changing NOS mRNA
Inhibitor
Increases choline uptake; bell-shaped dose-response
Antiaggregant, reported as mediated mainly via inhibition of thromboxane A2 metabolism
modulates
positive modulator
raises density
restores
reduces adhesion
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Piracetam is currently listed by more trusted vendors (3), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.